ABBV vs BDX
By Alex · Tickerpine
AbbVie Inc. vs Becton, Dickinson and Company, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | ABBV | BDX |
|---|---|---|
| Price | $285.64 | $198.91 |
| Market cap | $504.76B | $54.18B |
| P/E ratio | 80.5 | 46.3 |
| ROE | — | 6.61% |
| Profit margin | 9.80% | 4.19% |
| Revenue growth | 10.20% | 5.40% |
| Dividend yield | 2.42% | 2.11% |
| Beta | 0.23 | 0.28 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
ABBV vs BDX in plain English
- ABBV is the bigger company — about 9.3× the market cap of BDX.
- BDX is cheaper on earnings (P/E 46.3 vs 80.5).
- ABBV is growing revenue faster (10% vs 5%).
- ABBV has the higher dividend yield (2.42% vs 2.11%).
How would $1,000 have done in each?
ABBV return calculator
See what $1,000 in AbbVie Inc. would be worth today.
BDX return calculator
See what $1,000 in Becton, Dickinson and Company would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.